Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients

by Shabaz Majid, Lisa Rydén, Jonas Manjer
Published 2018-03-01

Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases

by Shabaz Majid, Lisa Rydén, Jonas Manjer
Published 2019-06-01

Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.

by Susann Busch, Lisa Rydén, Olle Stål, Karin Jirström, Göran Landberg
Published 2012-01-01

Artificial neural network models to predict nodal status in clinically node-negative breast cancer

by Looket Dihge, Mattias Ohlsson, Patrik Edén, Pär-Ola Bendahl, Lisa Rydén
Published 2019-06-01

The prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women.

by Janna Sand-Dejmek, Roy Ehrnström, Pontus Berglund, Tommy Andersson, Lisa Ryden
Published 2013-01-01

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.

by Sara Alkner, Pär-Ola Bendahl, Anna Ehinger, Kristina Lövgren, Lisa Rydén, Mårten Fernö
Published 2016-01-01

Tumor tissue protein signatures reflect histological grade of breast cancer.

by Petter Skoog, Mattias Ohlsson, Mårten Fernö, Lisa Rydén, Carl A K Borrebaeck, Christer Wingren
Published 2017-01-01

Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions—a feasibility study

by Kristina Åhsberg, Anna Gardfjell, Emma Nimeus, Rogvi Rasmussen, Catharina Behmer, Sophia Zackrisson, Lisa Ryden
Published 2020-05-01

Barriers and facilitators for individualized rehabilitation during breast cancer treatment – a focus group study exploring health care professionals’ experiences

by Ulrika Olsson Möller, Ing-Marie Olsson, Katarina Sjövall, Ingela Beck, Lisa Rydén, Marlene Malmström
Published 2020-03-01

Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression

by Frida Björk Gunnarsdottir, Nathalie Auoja, Pär-Ola Bendahl, Lisa Rydén, Mårten Fernö, Karin Leandersson
Published 2020-01-01

Psychological Resilience and Health-Related Quality of Life in 418 Swedish Women with Primary Breast Cancer: Results from a Prospective Longitudinal Study

by Åsa Mohlin, Pär-Ola Bendahl, Cecilia Hegardt, Corinna Richter, Ingalill Rahm Hallberg, Lisa Rydén
Published 2021-05-01

The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.

by Sara Jansson, Pär-Ola Bendahl, Dorthe Aamand Grabau, Anna-Karin Falck, Mårten Fernö, Kristina Aaltonen, Lisa Rydén
Published 2014-01-01

Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden

by Katarina Velickovic, Ingalill Rahm Hallberg, Ulrika Axelsson, Carl A. K. Borrebaeck, Lisa Rydén, Per Johnsson, Johanna Månsson
Published 2020-05-01

A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study

by Ulrika Axelsson, Lisa Rydén, Per Johnsson, Patrik Edén, Johanna Månsson, Ingalill Rahm Hallberg, Carl A. K. Borrebaeck
Published 2018-08-01

Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer

by Karoline Berger, Sara Rhost, Svanheiður Rafnsdóttir, Éamon Hughes, Ylva Magnusson, Maria Ekholm, Olle Stål, Lisa Rydén, Göran Landberg
Published 2021-02-01

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast...

by Julia Tutzauer, Martin Sjöström, Pär-Ola Bendahl, Lisa Rydén, Mårten Fernö, L M Fredrik Leeb-Lundberg, Sara Alkner
Published 2020-01-01

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up

by Christine Lundgren, Pär-Ola Bendahl, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén
Published 2020-12-01

The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance

by Ulrik Narbe, Pär-Ola Bendahl, Kristina Aaltonen, Mårten Fernö, Carina Forsare, Charlotte Levin Tykjær Jørgensen, Anna-Maria Larsson, Lisa Rydén
Published 2020-07-01

Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells

by Carina Forsare, Pär-Ola Bendahl, Eric Moberg, Charlotte Levin Tykjær Jørgensen, Sara Jansson, Anna-Maria Larsson, Kristina Aaltonen, Lisa Rydén
Published 2020-04-01

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications

by Charlotte Levin Tykjær Jørgensen, Anna-Maria Larsson, Carina Forsare, Kristina Aaltonen, Sara Jansson, Rachel Bradshaw, Pär-Ola Bendahl, Lisa Rydén
Published 2021-03-01